)
)
Stayble Therapeutics Investor Relations Material
Latest events
CEO Sitdown with Kalqyl Q4 2023
Stayble Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Stayble Therapeutics
Access all reports
Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Its portfolio includes StaYble, a combination of two drugs that are already approved for use in humans and administered as separate mechanisms at complementary sites of action, with the goal of achieving synergy, which is the treatment of pain through several independent but related mechanisms.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
STABL
Country
🇸🇪 Sweden